{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:03:31Z","timestamp":1778241811427,"version":"3.51.4"},"reference-count":40,"publisher":"BMJ","funder":[{"name":"Rebecca Hotchkiss International Scholar Exchange Program","award":["n\/a - stipend for travel"],"award-info":[{"award-number":["n\/a - stipend for travel"]}]},{"name":"Canadian Network of MS Clinics","award":["n\/a - Fellowship award"],"award-info":[{"award-number":["n\/a - Fellowship award"]}]},{"name":"University of Calgary Medical Group","award":["n\/a - fellowship salary award"],"award-info":[{"award-number":["n\/a - fellowship salary award"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,7,15]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Corticosteroid treatment of multiple sclerosis (MS) relapses is assumed to improve the speed of relapse recovery, without modifying long-term disability risk. We aimed to re-evaluate this assumption in a large cohort of individuals with MS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Individuals with clinically definite MS and \u22653 Expanded Disability Status Scale (EDSS) measurements over \u226512\u2009months were identified within the international neuroimmunology registry MSBase. Individuals were required to have \u22651 relapse, with complete information on relapse treatment, phenotype and severity for all documented relapses. The primary outcome was disability worsening confirmed over 12 months. The association of the cumulative number of steroid-treated and untreated relapses (as a time-varying exposure) with disability worsening was evaluated with Cox proportional hazards.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 3673 individuals met the inclusion criteria (71% female, mean age 38 years, mean disability EDSS step 2); 5809 relapses (4671 treated\/1138 untreated) were captured (annualised relapse rate 0.19). Over the study period (total 30\u2009175 person-years), 32.7% reached the outcome of confirmed disability worsening (median survival time 5.2 years). Non-treated relapses were associated with a higher risk of disability worsening (HR 1.72, 95%\u2009CI 1.57 to 1.88) than steroid-treated relapses (HR 1.50, 95%\u2009CI 1.43 to 1.57). This association was modified by the efficacy of disease-modifying therapy at the time of relapse.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results suggest that a lack of steroid treatment of MS relapses is associated with a higher risk of future disability worsening. Hence, corticosteroid treatment of MS relapses may impact not only the speed of recovery but also the severity of residual structural damage.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336343","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:20:15Z","timestamp":1753723215000},"page":"jnnp-2025-336343","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8544-3171","authenticated-orcid":false,"given":"Jodie I","family":"Roberts","sequence":"first","affiliation":[{"name":"Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada"},{"name":"CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7294-9723","authenticated-orcid":false,"given":"Sifat","family":"Sharmin","sequence":"additional","affiliation":[{"name":"CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Horakova","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center of Clinical Neuroscience, Charles University First Faculty of Medicine, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Kubala Havrdova","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center of Clinical Neuroscience, Charles University First Faculty of Medicine, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"Ozakbas,","sequence":"additional","affiliation":[{"name":"Medical Point Hospital, Izmir University of Economics, Konak\/Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2902-5589","authenticated-orcid":false,"given":"Alessandra","family":"Lugaresi","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Biomediche e Neuromotorie, Universit\u00e0 di Bologna, Bologna, Italy"},{"name":"IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Tomassini","sequence":"additional","affiliation":[{"name":"Institute for Advanced Biomedical Technologies (ITAB) and Centre for Rehabilitation, Disability and Sport Medicine (CARES), Department of Neurosciences, Imaging and Clinical Sciences, Gabriele d\u2019Annunzio University of Chieti and Pescara, Chieti, Italy"},{"name":"Clinical Neurology, SS Annunziata Hospital, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raed","family":"Alroughani","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Al-Amiri Hospital, Sharq, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Buzzard","sequence":"additional","affiliation":[{"name":"Eastern Health Clinical School, Monash University, Box Hill Hospital, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Skibina","sequence":"additional","affiliation":[{"name":"Eastern Health Clinical School, Monash University, Box Hill Hospital, Melbourne, Victoria, Australia"},{"name":"Department of Neurology, The Alfred, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cavit","family":"Boz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Farabi Hospital, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recai","family":"Turkoglu","sequence":"additional","affiliation":[{"name":"Istsanbul Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Maimone","sequence":"additional","affiliation":[{"name":"Centro Sclerosi Multipla, UOC Neurologia, Azienda Ospedaliera Cannizzaro, Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassem","family":"Yamout","sequence":"additional","affiliation":[{"name":"Neurology Institute, Harley Street Medical Center, Abu Dhabi, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-6063","authenticated-orcid":false,"given":"Samia Joseph","family":"Khoury","sequence":"additional","affiliation":[{"name":"Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Spitaleri","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera di Rilievo Nazionale e di Alta Specialita San Giuseppe Moscati, Avellino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Lechner-Scott","sequence":"additional","affiliation":[{"name":"Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia"},{"name":"Hunter New England Health, John Hunter Hospital, Newcastle, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Girard","sequence":"additional","affiliation":[{"name":"CRCHUM, CHUM MS Center and Department of Neurosciences, Universite de Montreal Faculte de Medecine, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Duquette","sequence":"additional","affiliation":[{"name":"CRCHUM, CHUM MS Center and Department of Neurosciences, Universite de Montreal Faculte de Medecine, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Al-Asmi","sequence":"additional","affiliation":[{"name":"College of Medicine & Health Sciences, Sultan Qaboos University, Al-Khodh, Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"Ampapa","sequence":"additional","affiliation":[{"name":"Nemocnice Jihlava, Jihlava, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-7155","authenticated-orcid":false,"given":"Matteo","family":"Foschi","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, MS Center, Neurology Unit, Ospedale Santa Maria delle Croci, Ravenna, Italy"},{"name":"Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Surcinelli","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, MS Center, Neurology Unit, Ospedale Santa Maria delle Croci, Ravenna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6923-0846","authenticated-orcid":false,"given":"Francesco","family":"Patti","sequence":"additional","affiliation":[{"name":"University of Catania Department of Surgical and Medical Sciences and Advanced Technologies 'G.F. Ingrassia\u2019, Catania, Italy"},{"name":"Multiple Sclerosis Unit, Azienda Ospedaliero Universitaria Policlinico G Rodolico San Marco, Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Van Pesch","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium"},{"name":"UCLouvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ramo-Tello","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Hospital Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"S\u00e1nchez-Menoyo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital de Galdakao-Usansolo, Galdakao, Spain"},{"name":"Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Altintas","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine and Koc University Research Center for Translational Medicine (KUTTAM), Ko\u00e7 University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Grammond","sequence":"additional","affiliation":[{"name":"CISSS de Chaudiere-Appalaches, Levis, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Cartechini","sequence":"additional","affiliation":[{"name":"Neurology Unit, P O Unico Macerata, AST Macerata, Macerata, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tunde","family":"Csepany","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Debrecen Faculty of Medicine, Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Laureys","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Ghent, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Willekens","sequence":"additional","affiliation":[{"name":"Department of Neurology, Antwerp University Hospital and Translational Neurosciences Research Group, University of Antwerp Faculty of Medicine and Health Sciences, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izanne","family":"Roos","sequence":"additional","affiliation":[{"name":"CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-1376","authenticated-orcid":false,"given":"Tomas","family":"Kalincik","sequence":"additional","affiliation":[{"name":"CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MSBase","family":"Study Group","sequence":"additional","affiliation":[{"name":"The Alfred, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"2025072810201342000_jnnp-2025-336343v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac016"},{"key":"2025072810201342000_jnnp-2025-336343v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.08.004"},{"key":"2025072810201342000_jnnp-2025-336343v1.3","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514528762"},{"key":"2025072810201342000_jnnp-2025-336343v1.4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1352458516643392","article-title":"Contribution of different relapse phenotypes to disability in multiple sclerosis","volume":"23","author":"Stewart","year":"2017","journal-title":"Mult Scler"},{"key":"2025072810201342000_jnnp-2025-336343v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.2.272"},{"key":"2025072810201342000_jnnp-2025-336343v1.6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.51.2.529","article-title":"Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS","volume":"51","author":"Sellebjerg","year":"1998","journal-title":"Neurology (ECronicon)"},{"key":"2025072810201342000_jnnp-2025-336343v1.7","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200376","article-title":"Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey","volume":"15","author":"Roberts","year":"2025","journal-title":"Neurol Clin Pract"},{"key":"2025072810201342000_jnnp-2025-336343v1.8","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00415-016-8183-3","article-title":"Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse","volume":"263","author":"Jongen","year":"2016","journal-title":"J Neurol"},{"key":"2025072810201342000_jnnp-2025-336343v1.9","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3182764f91"},{"key":"2025072810201342000_jnnp-2025-336343v1.10","doi-asserted-by":"publisher","DOI":"10.4065\/81.10.1361"},{"key":"2025072810201342000_jnnp-2025-336343v1.11","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.arth.2015.03.036","article-title":"High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review","volume":"30","author":"Mont","year":"2015","journal-title":"J Arthroplasty"},{"key":"2025072810201342000_jnnp-2025-336343v1.12","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506070775"},{"key":"2025072810201342000_jnnp-2025-336343v1.13","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516662728"},{"key":"2025072810201342000_jnnp-2025-336343v1.14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1212\/WNL.0b013e31825fded9","article-title":"Interferon-\u03b2 and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS","volume":"79","author":"Stewart","year":"2012","journal-title":"Neurology (ECronicon)"},{"key":"2025072810201342000_jnnp-2025-336343v1.15","unstructured":"World Bank . World Bank Country and Lending Groups. Current Classification by Income, Available: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups [Accessed 25 Mar 2024]."},{"key":"2025072810201342000_jnnp-2025-336343v1.16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv258"},{"key":"2025072810201342000_jnnp-2025-336343v1.17","doi-asserted-by":"publisher","DOI":"10.1007\/s004150070172"},{"key":"2025072810201342000_jnnp-2025-336343v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00116-6"},{"key":"2025072810201342000_jnnp-2025-336343v1.19","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/WNL.57.7.1239","article-title":"Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS","volume":"57","author":"Zivadinov","year":"2001","journal-title":"Neurology (ECronicon)"},{"key":"2025072810201342000_jnnp-2025-336343v1.20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.50.5.511"},{"key":"2025072810201342000_jnnp-2025-336343v1.21","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain (Bacau)"},{"key":"2025072810201342000_jnnp-2025-336343v1.22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00415-017-8726-2","article-title":"Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes","volume":"265","author":"Di Gregorio","year":"2018","journal-title":"J Neurol"},{"key":"2025072810201342000_jnnp-2025-336343v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.03.050"},{"key":"2025072810201342000_jnnp-2025-336343v1.24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2399"},{"key":"2025072810201342000_jnnp-2025-336343v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.06.023"},{"key":"2025072810201342000_jnnp-2025-336343v1.26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology (ECronicon)"},{"key":"2025072810201342000_jnnp-2025-336343v1.27","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1093\/brain\/awad218","article-title":"The risk of secondary progressive multiple sclerosis is geographically determined but modifiable","volume":"146","author":"Sharmin","year":"2023","journal-title":"Brain (Bacau)"},{"key":"2025072810201342000_jnnp-2025-336343v1.28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/13524585221129963","article-title":"Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis","volume":"29","author":"Calocer","year":"2023","journal-title":"Mult Scler"},{"key":"2025072810201342000_jnnp-2025-336343v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06250-x"},{"key":"2025072810201342000_jnnp-2025-336343v1.30","first-page":"e881","article-title":"Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis","volume":"97","author":"Gray-Roncal","year":"2021","journal-title":"Neurology (ECronicon)"},{"key":"2025072810201342000_jnnp-2025-336343v1.31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ana.27093","article-title":"Relapse-Associated and Relapse-Independent Contribution to Overall Expanded Disability Status Scale Progression in Multiple Sclerosis Patients Diagnosed in Different Eras","volume":"97","author":"Montobbio","year":"2024","journal-title":"Ann Neurol"},{"key":"2025072810201342000_jnnp-2025-336343v1.32","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231151951"},{"key":"2025072810201342000_jnnp-2025-336343v1.33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamaneurol.2024.1961","article-title":"Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis","volume":"81","author":"Gavoille","year":"2024","journal-title":"JAMA Neurol"},{"key":"2025072810201342000_jnnp-2025-336343v1.34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7224\/1537-2073.2020-114","article-title":"Predicting Long-term Disability in Multiple Sclerosis: A Narrative Review of Current Evidence and Future Directions","volume":"24","author":"Weinstock-Guttman","year":"2022","journal-title":"Int J MS Care"},{"key":"2025072810201342000_jnnp-2025-336343v1.35","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad278"},{"key":"2025072810201342000_jnnp-2025-336343v1.36","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513508835"},{"key":"2025072810201342000_jnnp-2025-336343v1.37","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jamaneurol.2018.0024","article-title":"Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial","volume":"75","author":"Morrow","year":"2018","journal-title":"JAMA Neurol"},{"key":"2025072810201342000_jnnp-2025-336343v1.38","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(15)61137-0","article-title":"Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial","volume":"386","author":"Le Page","year":"2015","journal-title":"The Lancet"},{"key":"2025072810201342000_jnnp-2025-336343v1.39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ene.13851","article-title":"Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial","volume":"26","author":"Herv\u00e1s-Garc\u00eda","year":"2019","journal-title":"Eur J Neurol"},{"key":"2025072810201342000_jnnp-2025-336343v1.40","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515590648"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:20:18Z","timestamp":1753723218000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":40,"alternative-id":["10.1136\/jnnp-2025-336343"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336343","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}